Cargando…

To the Editor—Atropine: Hero or villain in cardioneuroablation?

Detalles Bibliográficos
Autores principales:	Pachon-M, Jose Carlos, Pachon-M, Enrique I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289067/ https://www.ncbi.nlm.nih.gov/pubmed/35860773 http://dx.doi.org/10.1016/j.hrcr.2022.04.016

Ejemplares similares

Author’s Reply—Atropine: Hero or villain in cardioneuroablation?
por: Thurber, Clinton J., et al.
Publicado: (2022)

Cardioneuroablation: Where are we at?
por: Pachon, Jose Carlos, et al.
Publicado: (2023)

Cardioneuroablation for treating functional bradyarrhythmias. How much is enough?
por: Pachon-M, J.C., et al.
Publicado: (2021)

Cardioneuroablation: Don’t forget atrioventricular node innervation
por: Pachon-M, Jose Carlos, et al.
Publicado: (2022)

Heroes and Villains of Finance
por: Baldwin, Adam
Publicado: (2015)

Treatment of Symptomatic Functional Atrioventricular Block by Cardioneuroablation as an Alternative to Pacemaker Implantation
por: Pachon-M, Jose Carlos, et al.
Publicado: (2022)

To the Editor— The proper usage of electroanatomic mapping–guided cardioneuroablation
por: Aksu, Tolga, et al.
Publicado: (2018)

Science heroes and villains of 2008
Publicado: (2008)

Reply to the Editor— The proper usage of electroanatomic mapping–guided cardioneuroablation
por: Antolic, Bor, et al.
Publicado: (2018)

Cardioneuroablation for Treating AV Functional Block Without Pacemaker Implantation: Does it Really Work?
por: Pachon, José C., et al.
Publicado: (2020)

Cancer-associated fibroblasts—heroes or villains?
por: Gieniec, Krystyna A., et al.
Publicado: (2019)

Carotid sinus syndrome treated by cardioneuroablation: Is sinus node denervation enough? Insights from a syncope recurrence report
por: Zerpa Acosta, Juan Carlos, et al.
Publicado: (2022)

Glucose and glycogen in the diabetic kidney: Heroes or villains?
por: Sullivan, Mitchell A., et al.
Publicado: (2019)

“Heroes” and “Villains” of World History across Cultures
por: Hanke, Katja, et al.
Publicado: (2015)

Villains or heroes? The raison d'être of viruses
por: Watanabe, Tokiko, et al.
Publicado: (2020)

The Renin-Angiotensin System in Huntington’s Disease: Villain or Hero?
por: Machado, Thatiane C.G., et al.
Publicado: (2020)

Dietary inorganic nitrate: From villain to hero in metabolic disease?
por: McNally, Ben, et al.
Publicado: (2015)

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
por: Pintori, Nicholas, et al.
Publicado: (2023)

Regarding ‘Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope’
por: Martínez-Alday, Jesús Daniel, et al.
Publicado: (2023)

Cardioneuroablation instead of pacemaker implantation in a young patient suffering from permanent 2:1 atrioventricular block after a slow pathway ablation
por: Bulava, Alan, et al.
Publicado: (2020)

Heroes or Villains? The Dark Side of Charismatic Leadership and Unethical Pro-organizational Behavior
por: Zhang, Xue, et al.
Publicado: (2020)

Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
por: Egeli, Bugra Han, et al.
Publicado: (2021)

Acute pulmonary embolism: An unseen villain in COVID-19
por: Agstam, Sourabh, et al.
Publicado: (2020)

Hero Turned Villain: Identification of Components of the Sex Pheromone of the Tomato Bug, Nesidiocoris tenuis
por: Hall, David R., et al.
Publicado: (2021)

Plastics—Villain or Hero? Polymers and Recycled Polymers in Mineral and Metallurgical Processing—A Review
por: Devasahayam, Sheila, et al.
Publicado: (2019)

Myroides: A Rare but Hard-to-crack Villain in a Critical Care Setup
por: Mahendran, Arul Janakiammal, et al.
Publicado: (2021)

Amphetamine and atropine interaction: A reason for concern?
por: de Hobaika, Adriano Bechara, et al.
Publicado: (2014)

Is a minimum dose of atropine in children justified?
por: Prakash, Smita, et al.
Publicado: (2017)

Procedural Characteristics and Medications to Prevent Sinus Node Artery Occlusion During Cardioneuroablation
por: Debruyne, Philippe
Publicado: (2022)

FMS-related tyrosine kinase 3 internal tandem duplication (FLT3-ITD): a villain among others
por: de Arruda, Vanessa Y.N., et al.
Publicado: (2017)

2020: The Heroes with the Lamp and Corona-Virus Pandemic
por: Bahramnezhad, Fatemeh, et al.
Publicado: (2021)

Transient global amnesia complicating dobutamine–atropine stress echocardiography
por: Agarwal, Vikram, et al.
Publicado: (2015)

Compliance in usage of low-dose atropine for prevention of progression of myopia in Indian children
por: Dalal, Devanshi M, et al.
Publicado: (2021)

Efficacy of low-dose atropine to reduce myopia progression among Indian children
por: Sivaraman, Viswanathan, et al.
Publicado: (2021)

Reply: Procedural Characteristics and Medications to Prevent Sinus Node Artery Occlusion During Cardioneuroablation
por: Rivarola, Esteban W., et al.
Publicado: (2022)

Sugammadex-induced atropine-resistant bradycardia: clinical, pathophysiologic, and electrocardiographic considerations
por: Kounis, Nicholas G., et al.
Publicado: (2020)

True Heroes of COVID-19 Battle – Our Nightingales
por: Francis, Varsha, et al.
Publicado: (2020)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Computed tomography-based identification of ganglionated plexi to guide cardioneuroablation for vasovagal syncope
por: Francia, Pietro, et al.
Publicado: (2023)

Data annotators: The unacclaimed heroes of artificial intelligence revolution in ophthalmology
por: Gurnani, Bharat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_juus0ndnntj0f97fe1uhi41bj1